2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Massimo Girardis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection Enoxaparin, Methylprednisolone, unfractionated heparin - Covid19, SARS-CoV Infection | Phase 3 | Unknown | Massimo Girardis | 210 | 2020-11-25 | 2021-05-06 |
| Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock. IgM-enriched polyclonal immunoglobulins titer-based treatment, IgM-enriched polyclonal immunoglobulins Flat treatment - Shock, Septic, Sepsis | Phase 3 | Unknown | Massimo Girardis | 356 | 2020-05-01 | 2021-05-06 |
COVID-19 (1) · Critical Illness (1) · Hemostatic Disorders (1) · Pneumonia, Viral (1) · Sepsis (1) · Severe Acute Respiratory Syndrome (1) · Shock, Septic (1)
Enoxaparin (1) · Heparin (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · pentaglobulin (1)
Italy (2)
2018 (1)